Experts from BRG recently discussed the two presidential candidates' stances on key healthcare issues, including drug pricing ...
Last year, researchers looked at the directories of the nation’s five largest health plans and found that four out of five entries were inaccurate. This is more than a minor inconvenience.
Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.
Mental health platform Headspace launched a new feature last week called Ebb, an empathetic AI companion, to help people process their emotions. Santa Monica, California-based Headspace offers an ...
The healthcare industry is on the cusp of a transformation similar to that witnessed by the banking industry 15 to 20 years ago. Like healthcare, banking is a very personal yet highly regulated ...
Yet another Bay Area healthcare AI startup was born this week. On Tuesday, San Francisco-based generative AI voice platform Parakeet Health formally launched and announced $3 million in seed funding.
Shortly after releasing a scathing interim report in July that revealed how three players dominate the pharmacy benefit manager market and raise drug costs for patients, the Federal Trade ...
The writing has been on the wall for years: the shift away from fee for service to value-based pay is coming. Recently that message, now in bold type, proliferated to every healthcare media outlet ...
Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of the chronic respiratory condition. Upstream Bio is pursuing a ...
Bipartisan Congressional scrutiny has shone a harsh spotlight on the many tactics used by pharmacy benefit managers (PBMs) and Big Pharma that contribute to the sky high costs of prescription ...
The 2024 election is nearing the corner and has major implications for the healthcare industry, from abortion to drug pricing. During the Reuters Total Health Conference held in Chicago on Tuesday ...
A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...